NEW YORK – P23 Labs has received Emergency Use Authorization for its coronavirus PCR test from the US Food and Drug Administration.
The TaqPath SARS-CoV-2 test is authorized for use with oropharyngeal, nasopharyngeal, anterior nasal, and mid-turbinate nasal swabs, as well as nasopharyngeal wash, nasal aspirate specimens, and bronchoalveolar lavage samples. In addition, it can use saliva samples collected using OraSure Technologies' Omnigene Oral OM-505 saliva collection device.